Stockreport

Pharvaris Highlights Properties of Deucrictibant in Data Presentations at Recent Congresses [Yahoo! Finance]

Pharvaris N.V. - Ordinary Shares  (PHVS) 
PDF High treatment satisfaction of deucrictibant driven by favorable effectiveness subdomain score compared to placebo ZUG, Switzerland, June 04, 2024 (GLOBE NEWSWIRE) -- [Read more]